ANXA7 and breast cancer: In addition, Srivastava et al. showed that high expression of ANXA7 was a strong predictor of reduced disease-free survival (Srivastava et al., 2001a), and thus highlights its potential as a prognostic biomarker to predict breast cancer patients’ survival.